Parties and Scope
Identify legal parties, sites, products, services, markets, term, and governed quality systems.
4.8
on G2
Free Pharma & Biotech Template
GMP quality responsibilities agreement between [company] and [partner]
Use this template to gMP quality responsibilities agreement between [company] and [partner].
| Field | Details |
|---|---|
| Category | Pharma & Biotech |
| Owner | [Team or owner] |
| Version | [Version number] |
| Effective Date | [Date] |
| Review Cycle | [Monthly / Quarterly / Annual / Event-based] |
| Status | [Draft / In Review / Approved] |
Identify legal parties, sites, products, services, markets, term, and governed quality systems.
| Item | Details | Owner | Status |
|---|---|---|---|
| [Item or requirement] | [Describe the relevant detail, evidence, or decision] | [Owner] | [Open / Complete] |
| [Item or requirement] | [Describe the relevant detail, evidence, or decision] | [Owner] | [Open / Complete] |
[Add context, assumptions, exceptions, evidence links, screenshots, calculations, or reviewer comments.]
Define responsibilities for manufacturing, testing, release, validation, training, complaints, and QP or QA disposition.
| Item | Details | Owner | Status |
|---|---|---|---|
| [Item or requirement] | [Describe the relevant detail, evidence, or decision] | [Owner] | [Open / Complete] |
| [Item or requirement] | [Describe the relevant detail, evidence, or decision] | [Owner] | [Open / Complete] |
[Add context, assumptions, exceptions, evidence links, screenshots, calculations, or reviewer comments.]
Describe supplier qualification, material release, reference standards, sample retention, and laboratory controls.
| Item | Details | Owner | Status |
|---|---|---|---|
| [Item or requirement] | [Describe the relevant detail, evidence, or decision] | [Owner] | [Open / Complete] |
| [Item or requirement] | [Describe the relevant detail, evidence, or decision] | [Owner] | [Open / Complete] |
[Add context, assumptions, exceptions, evidence links, screenshots, calculations, or reviewer comments.]
Set notification timelines, investigation ownership, approval rights, CAPA tracking, and effectiveness checks.
| Item | Details | Owner | Status |
|---|---|---|---|
| [Item or requirement] | [Describe the relevant detail, evidence, or decision] | [Owner] | [Open / Complete] |
| [Item or requirement] | [Describe the relevant detail, evidence, or decision] | [Owner] | [Open / Complete] |
[Add context, assumptions, exceptions, evidence links, screenshots, calculations, or reviewer comments.]
Define change categories, prior approval requirements, notification timelines, and implementation holds.
| Item | Details | Owner | Status |
|---|---|---|---|
| [Item or requirement] | [Describe the relevant detail, evidence, or decision] | [Owner] | [Open / Complete] |
| [Item or requirement] | [Describe the relevant detail, evidence, or decision] | [Owner] | [Open / Complete] |
[Add context, assumptions, exceptions, evidence links, screenshots, calculations, or reviewer comments.]
Describe audit rights, record retention, data integrity expectations, batch record access, and subcontractor controls.
| Item | Details | Owner | Status |
|---|---|---|---|
| [Item or requirement] | [Describe the relevant detail, evidence, or decision] | [Owner] | [Open / Complete] |
| [Item or requirement] | [Describe the relevant detail, evidence, or decision] | [Owner] | [Open / Complete] |
[Add context, assumptions, exceptions, evidence links, screenshots, calculations, or reviewer comments.]
Define inspection support, market actions, filings, recalls, and authority notification responsibilities. Use clear contractual quality language without legal boilerplate.
| Item | Details | Owner | Status |
|---|---|---|---|
| [Item or requirement] | [Describe the relevant detail, evidence, or decision] | [Owner] | [Open / Complete] |
| [Item or requirement] | [Describe the relevant detail, evidence, or decision] | [Owner] | [Open / Complete] |
[Add context, assumptions, exceptions, evidence links, screenshots, calculations, or reviewer comments.]
Document review conclusions, approvals, unresolved items, and next review date.
| Role | Name | Date | Notes |
|---|---|---|---|
| Preparer | [Name] | [Date] | [Notes] |
| Reviewer | [Name] | [Date] | [Notes] |
| Approver | [Name] | [Date] | [Notes] |
Template Structure
Use this pharma & biotech template as a starting point, then customize each section to match your internal workflow, evidence, and signoff needs.
Identify legal parties, sites, products, services, markets, term, and governed quality systems.
Define responsibilities for manufacturing, testing, release, validation, training, complaints, and QP or QA disposition.
Describe supplier qualification, material release, reference standards, sample retention, and laboratory controls.
Set notification timelines, investigation ownership, approval rights, CAPA tracking, and effectiveness checks.
Define change categories, prior approval requirements, notification timelines, and implementation holds.
Describe audit rights, record retention, data integrity expectations, batch record access, and subcontractor controls.
Define inspection support, market actions, filings, recalls, and authority notification responsibilities. Use clear contractual quality language without legal boilerplate.
Write a Pharma/Biotech Quality Agreement. Structure with these Markdown sections:
Identify legal parties, sites, products, services, markets, term, and governed quality systems.
Define responsibilities for manufacturing, testing, release, validation, training, complaints, and QP or QA disposition.
Describe supplier qualification, material release, reference standards, sample retention, and laboratory controls.
Set notification timelines, investigation ownership, approval rights, CAPA tracking, and effectiveness checks.
Define change categories, prior approval requirements, notification timelines, and implementation holds.
Describe audit rights, record retention, data integrity expectations, batch record access, and subcontractor controls.
Define inspection support, market actions, filings, recalls, and authority notification responsibilities.
Use clear contractual quality language without legal boilerplate.
This agreement covers GMP manufacture and packaging of DBX-100 tablets for US and EU markets.
The CMO executes manufacturing and testing; Docsie Pharma retains final batch disposition authority.
All API lots require QA release before dispensing.
Critical deviations must be reported to Docsie Pharma within one business day.
Process, site, method, and supplier changes require prior written approval.
Batch records are retained for at least one year after product expiry.
Regulatory inspections affecting DBX-100 require same-day notification.
Record a walkthrough, training session, or process demonstration. Docsie AI turns it into structured documentation using this template as the starting framework.
Use the template manually, or let Docsie generate the first draft from source footage.
APQR report for [product_name] covering [review_period]
Controlled record for manufacturing [product] batch [batch_number]
Corrective and preventive action plan for [quality_issue]
Controlled assessment for proposed GMP change to [system_or_process]
Protocol for validating cleaning of [equipment_or_process_train]
GMP deviation investigation for [event] affecting [batch_or_process]
Template FAQ
Common questions about using and generating a quality Agreement.
Q: What is a quality Agreement?
A: A quality Agreement is a structured document for gmp quality responsibilities agreement between [company] and [partner].
Q: Can I download this quality Agreement as Word or PDF?
A: Yes. This page includes free downloads in DOCX, PDF, and Markdown formats so you can edit, share, or import the template into your documentation system.
Q: Can Docsie generate this from a video?
A: Yes. Upload a process walkthrough, training recording, or screen capture to Docsie, then use this template structure to generate a first draft automatically.